NASOPHARYNGEAL CARCINOMA
Clinical trials for NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smarter radiation aims to spare patients harsh side effects
Disease control Recruiting nowThis study is testing a more targeted approach to radiation therapy for nasopharyngeal cancer. It aims to see if focusing radiation only on specific areas of the neck, based on detailed scans, can reduce side effects like thyroid problems and swallowing issues while keeping cance…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Three-Pronged attack: new combo therapy aims to wipe out advanced throat cancer
Disease control Recruiting nowThis study is testing a new three-drug combination (gemcitabine, docetaxel, and toripalimab) given before standard radiation therapy for people with a specific type of advanced throat cancer (EBV-positive nasopharyngeal carcinoma). The goal is to see if this approach is safe, fea…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo targets tough cancers in major trial
Disease control Recruiting nowThis study is testing a new two-drug combination (BL-B01D1 + SI-B003) for people with advanced lung cancer or throat cancer that has spread. The main goals are to see if the treatment can shrink tumors and to determine the safest and most effective dose. It will involve about 121…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Major trial tests Triple-Threat attack on advanced throat cancer
Disease control Recruiting nowThis large Phase 3 trial is testing whether adding a new immunotherapy drug (cadonilimab) and low-dose radiation to standard chemotherapy and radiation works better for people with newly diagnosed, advanced nasopharyngeal cancer. The study will compare the new combination to the …
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New Triple-Threat treatment trial for advanced throat cancer
Disease control Recruiting nowThis study is testing whether combining an immunotherapy drug (envafolimab) with standard chemotherapy, radiation, and another medication (endostatin) works better for advanced nasopharyngeal cancer. The trial will enroll 30 patients with high-risk, locally advanced cancer who ha…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Can less radiation be just as effective for throat cancer?
Disease control Recruiting nowThis study is for people with a specific intermediate-stage nasopharyngeal (upper throat) cancer that has responded well to initial drug treatment. It compares a lower dose of radiation to the standard dose, both given alongside immunotherapy. The goal is to see if the lower dose…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New Two-Pronged attack on tough cancers enters Mid-Stage testing
Disease control Recruiting nowThis study is testing whether a new drug called BL-B01D1 works better when combined with an existing immunotherapy (PD-1 antibody) to control advanced cancers that have spread. It will involve about 570 adults with non-small cell lung cancer, nasopharyngeal cancer, or other solid…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Cancer trial aims to cut radiation side effects without losing effectiveness
Disease control Recruiting nowThis study is testing whether a lower dose of radiation therapy works as well as the standard dose for certain patients with stage III nasopharyngeal cancer (a type of head and neck cancer). It will enroll about 593 patients in China who respond well to initial chemotherapy and i…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC